Invention Grant
- Patent Title: Matrix protein compositions for induction of apoptosis
- Patent Title (中): 用于诱导凋亡的基质蛋白组合物
-
Application No.: US12760074Application Date: 2010-04-14
-
Publication No.: US07960347B2Publication Date: 2011-06-14
- Inventor: Lars Hammarstrom , Stale Petter Lyngstadaas , Stina Gestrelius
- Applicant: Lars Hammarstrom , Stale Petter Lyngstadaas , Stina Gestrelius
- Applicant Address: CH Basel
- Assignee: Institut Straumann AG
- Current Assignee: Institut Straumann AG
- Current Assignee Address: CH Basel
- Agency: Rissman Hendricks & Oliverio, LLP
- Priority: DK199900336 19990310
- Main IPC: A01N61/00
- IPC: A01N61/00 ; A61K31/00 ; A61K38/00
Abstract:
Enamel matrix, enamel matrix derivatives and/or enamel matrix proteins or peptides may be used as therapeutic or prophylactic agents for inducing programmed cell death (apoptosis), in particular in the treatment or prevention of cancer or malignant or benign neoplasms.
Public/Granted literature
- US20100234298A1 MATRIX PROTEIN COMPOSITIONS FOR INDUCTION OF APOPTOSIS Public/Granted day:2010-09-16
Information query
